MICROPORT (00853) announced the first half 2025 financial results for Shanghai Microport Endovascular Medtech(Group)Co.,Ltd., showing revenue of approximately RMB 714 million, representing a year-over-year decrease of 9.24%. Net profit attributable to Shanghai Microport Endovascular Medtech(Group)Co.,Ltd. shareholders reached approximately RMB 315 million, down 22.03% compared to the same period last year.